News
6d
News-Medical.Net on MSNBest time for asthma meds? Try 4 pmChronotherapy for asthma reveals that afternoon inhaled corticosteroids significantly improve lung function and reduce ...
Exposing children with peanut allergy to proteins from the legume is an approved treatment to reduce the risk of allergic ...
The ASPEN randomized trial showed that novel brensocatib cut the annualized rate of pulmonary exacerbations by around 20% ...
Hazelnut oral immunotherapy was safe and effective, but cross-desensitization for patients who also had walnut and cashew ...
Sanofi and Regeneron's Dupixent (dupilumab) has been approved by the FDA for the treatment of chronic spontaneous urticaria ...
Data from the BroADen Phase 1b atopic dermatitis (AD) patient trial expected to be reported in 4Q25 Completed SAD/MAD dosing in KT-621 Phase 1 healthy volunteer trial with data to be reported in June ...
Anagnostou, MD, MSc, PhD, FACAAI, did not realize she was already on her way to becoming an allergist when working a ...
1d
Lansing State Journal on MSNWhat's making my nose run and eyes water? Allergy season starts in MichiganSpring is the season of growth, and as Michiganders say goodbye to snow, pollen is the next visitor. Here's more on the ...
6d
Health on MSN7 Tips for Raising a Child With Food AllergiesRaising a child with food allergies involves educating yourself about their allergies, having an emergency plan, and ...
The changes in behaviour you’ve described could be signs of depression, possibly triggered by the job loss. It may help to ...
On its way to generating sales of $14 billion in just its seventh full year on the market, Sanofi and Regeneron’s Dupixent ...
The most common adverse events recorders during the trial were asthma-related, nasopharyngitis, headaches and bronchitis. Tezepelumab is superior to currently used treatment because it blocks ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results